Literature DB >> 29033646

Cerebrovascular Events Secondary to Pulmonary Arteriovenous Malformation Based on Genetic Heterogeneity.

Güner Çelik1, Hüseyin Yurdakul2, Erkan Yildirim3.   

Abstract

Entities:  

Year:  2016        PMID： 29033646      PMCID： PMC5630112          DOI： 10.5152/npa.2016.16997

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN： 1300-0667            Impact factor:   1.339


× No keyword cloud information.
  13 in total

1.  Hereditary haemorrhagic telangiectasia with protein S deficiency in a family: a case report.

Authors:  A Wechalekar; L Parapia
Journal:  Eur J Haematol       Date:  2000-01       Impact factor: 2.997

2.  Clinical management of Rendu-Osler-Weber syndrome and genetic thrombophilia.

Authors:  Sebastiano Bianca; Nunzio Cutuli; Marco Bianca; Barbara Barrano; Antonella Cataliotti; Chiara Barone; Gabriella Milana
Journal:  Blood Coagul Fibrinolysis       Date:  2009-12       Impact factor: 1.276

3.  Two concurrent chromosomal aberrations involving interstitial deletion in 1q24.2q25.2 and inverted duplication and deletion in 10q26 in a patient with stroke associated with antithrombin deficiency and a patent foramen ovale.

Authors:  Tetsuya Kibe; Yuka Mori; Tohru Okanishi; Keiko Shimojima; Kenji Yokochi; Toshiyuki Yamamoto
Journal:  Am J Med Genet A       Date:  2011-01       Impact factor: 2.802

4.  Hereditary hemorrhagic telangiectasia, factor V Leiden and antiphospholipid syndrome: a case report.

Authors:  A Undas; S Bazan-Socha; J Swadzba; J Musial
Journal:  Blood Coagul Fibrinolysis       Date:  2002-01       Impact factor: 1.276

5.  Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations.

Authors:  M Moussouttas; P Fayad; M Rosenblatt; M Hashimoto; J Pollak; K Henderson; T Y Ma; R I White
Journal:  Neurology       Date:  2000-10-10       Impact factor: 9.910

6.  Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years.

Authors:  Wolfgang Lalouschek; Martin Schillinger; Kety Hsieh; Georg Endler; Susanne Tentschert; Wilfried Lang; Suzanne Cheng; Christine Mannhalter
Journal:  Stroke       Date:  2005-06-09       Impact factor: 7.914

7.  Coagulation abnormalities in adults with cryptogenic stroke and patent foramen ovale.

Authors:  S Chaturvedi
Journal:  J Neurol Sci       Date:  1998-10-08       Impact factor: 3.181

8.  Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale.

Authors:  Vesa Karttunen; Leena Hiltunen; Vesa Rasi; Elina Vahtera; Matti Hillbom
Journal:  Blood Coagul Fibrinolysis       Date:  2003-04       Impact factor: 1.276

9.  Prothrombin G20210A mutation, but not factor V Leiden, is a risk factor in patients with persistent foramen ovale and otherwise unexplained cerebral ischemia.

Authors:  C Lichy; K H Reuner; F Buggle; F Litfin; H Rickmann; A Kunze; T Brandt; A Grau
Journal:  Cerebrovasc Dis       Date:  2003       Impact factor: 2.762

10.  Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale.

Authors:  Alessandro Pezzini; Elisabetta Del Zotto; Mauro Magoni; Angelo Costa; Silvana Archetti; Mario Grassi; Nabil Maalikjy Akkawi; Alberto Albertini; Deodato Assanelli; Luigi Amedeo Vignolo; Alessandro Padovani
Journal:  Stroke       Date:  2003-01       Impact factor: 7.914
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.